Autophagy and hypoxia in colonic adenomas related to aggressive features.

Autophagy and hypoxia in colonic adenomas related to aggressive features.

AIM: The study investigated whether autophagic activity and hypoxia parallel the adenoma-carcinoma sequence. METHOD: The study comprised 120 tubular adenomas with high-grade dysplasia, including 22 with questionable evidence of invasion, 37 with definite stromal invasion and 29 with severely dysplas...

Full description

Bibliographic Details
Main Authors:	Giatromanolaki, A, Koukourakis, M, Koutsopoulos, A, Harris, A, Gatter, K, Sivridis, E
Format:	Journal article
Language:	English
Published:	2013

Similar Items

c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
by: Giatromanolaki, A, et al.
Published: (2004)

Inclusion of vasculature-related variables in the Dukes staging system of colon cancer.
by: Koukourakis, M, et al.
Published: (2005)

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
by: Giatromanolaki, A, et al.
Published: (2008)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
by: Koukourakis, M, et al.
Published: (2010)

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
by: Sivridis, E, et al.
Published: (2002)

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
by: Giatromanolaki, A, et al.
Published: (2003)

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas.
by: Giatromanolaki, A, et al.
Published: (2010)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
by: Koukourakis, M, et al.
Published: (2006)

Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.
by: Giatromanolaki, A, et al.
Published: (2013)

BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2004)

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2003)

Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
by: Giatromanolaki, A, et al.
Published: (2006)

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2004)

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
by: Giatromanolaki, A, et al.
Published: (2008)

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
by: Giatromanolaki, A, et al.
Published: (2001)

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
by: Giatromanolaki, A, et al.
Published: (2008)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
by: Koukourakis, M, et al.
Published: (2003)

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
by: Giatromanolaki, A, et al.
Published: (2003)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
by: Koukourakis, M, et al.
Published: (2003)

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.
by: Giatromanolaki, A, et al.
Published: (2003)

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
by: Koukourakis, M, et al.
Published: (2013)

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
by: Koukourakis, M, et al.
Published: (2006)

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
by: Koukourakis, M, et al.
Published: (2005)

LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.
by: Sivridis, E, et al.
Published: (2010)

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2002)

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
by: Giatromanolaki, A, et al.
Published: (2006)

Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer
by: Giatromanolaki, A, et al.
Published: (2007)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.
by: Sivridis, E, et al.
Published: (2002)

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
by: Giatromanolaki, A, et al.
Published: (2008)

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer.
by: Giatromanolaki, A, et al.
Published: (2002)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
by: Koukourakis, M, et al.
Published: (2005)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
by: Giatromanolaki, A, et al.
Published: (2008)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
by: Giatromanolaki, A, et al.
Published: (2008)

C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer.
by: Koukourakis, M, et al.
Published: (2006)

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
by: Giatromanolaki, A, et al.
Published: (2007)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival
by: Giatromanolaki, A, et al.
Published: (2011)

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
by: Giatromanolaki, A, et al.
Published: (2012)

Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
by: Sivridis, E, et al.
Published: (2002)

Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression in Non Small Cell Lung Cancer and Tumor-Associated Stroma
by: Michael I. Koukourakis, et al.
Published: (2005-01-01)

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy
by: Koukourakis, MI, et al.
Published: (2009)